NQO1 and cancer: Though previous studies demonstrate the importance of NQO1 signaling for the progressive phenotype in colorectal cancer [60] and GSTP1 is overexpressed in many cancers and linked to drug resistance [61], the molecular mechanisms of how these reductive enzymes involved in GBM proliferation remain unclear.